|
1
|
Lehmann JM, McKee DD, Watson MA, et al:
The human orphan nuclear receptor PXR is activated by compounds
that regulate CYP3A4 gene expression and cause drug interactions. J
Clin Invest. 102:1016–1023. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertilsson G, Heidrich J, Svensson K, et
al: Identification of a human nuclear receptor defines a new
signaling pathway for CYP3A induction. Proc Natl Acad Sci USA.
95:12208–12213. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kliewer SA, Moore JT, Wade L, et al: An
orphan nuclear receptor activated by pregnanes defines a novel
steroid signaling pathway. Cell. 92:73–82. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blumberg B, Sabbagh W Jr, Juguilon H, et
al: SXR, a novel steroid and xenobiotic-sensing nuclear receptor.
Genes Dev. 12:3195–3205. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kast HR, Goodwin B, Tarr PT, et al:
Regulation of multidrug resistance-associated protein 2 (ABCC2) by
the nuclear receptors pregnane X receptor, farnesoid X-activated
receptor, and constitutive androstane receptor. J Biol Chem.
277:2908–2915. 2002. View Article : Google Scholar
|
|
6
|
Geick A, Eichelbaum M and Burk O: Nuclear
receptor response elements mediate induction of intestinal MDR1 by
rifampin. J Biol Chem. 276:14581–14587. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goodwin B, Hodgson E and Liddle C: The
orphan human pregnane X receptor mediates the transcriptional
activation of CYP3A4 by rifampicin through a distal enhancer
module. Mol Pharmacol. 56:1329–1339. 1999.PubMed/NCBI
|
|
8
|
Kawana K, Ikuta T, Kobayashi Y, Gotoh O,
Takeda K and Kawajiri K: Molecular mechanism of nuclear
translocation of an orphan nuclear receptor, SXR. Mol Pharmacol.
63:524–531. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Kuehl P, Green ED, Touchman JW,
et al: The human pregnane X receptor: genomic structure and
identification and functional characterization of natural allelic
variants. Pharmacogenetics. 11:555–572. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Renaud JP, Rochel N, Ruff M, Vivat V,
Chambon P, Gronemeyer H and Moras D: Crystal structure of the
RAR-gamma ligand-binding domain bound to all-trans retinoic acid.
Nature. 378:681–689. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu HE, Stanley TB, Montana VG, et al:
Structural basis for antagonist-mediated recruitment of nuclear
co-repressors by PPARalpha. Nature. 415:813–817. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nolte RT, Wisely GB, Westin S, et al:
Ligand binding and co-activator assembly of the peroxisome
proliferator-activated receptor-gamma. Nature. 395:137–143. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watkins RE, Maglich JM, Moore LB, et al:
2.1 A crystal structure of human PXR in complex with the St. John’s
wort compound hyperforin. Biochemistry. 42:1430–1438. 2003.
|
|
14
|
Rosenfeld JM, Vargas R Jr, Xie W and Evans
RM: Genetic profiling defines the xenobiotic gene network
controlled by the nuclear receptor pregnane X receptor. Mol
Endocrinol. 17:1268–1282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guengerich FP: Cytochrome P-450 3A4:
regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol.
39:1–17. 1999. View Article : Google Scholar
|
|
16
|
Wrighton SA, Schuetz EG, Thummel KE, Shen
DD, Korzekwa KR and Watkins PB: The human CYP3A subfamily:
practical considerations. Drug Metab Rev. 32:339–361. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moore LB, Parks DJ, Jones SA, et al:
Orphan nuclear receptors constitutive androstane receptor and
pregnane X receptor share xenobiotic and steroid ligands. J Biol
Chem. 275:15122–15127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Runge-Morris M, Wu W and Kocarek TA:
Regulation of rat hepatic hydroxysteroid sulfotransferase
(SULT2-40/41) gene expression by glucocorticoids: evidence for a
dual mechanism of transcriptional control. Mol Pharmacol.
56:1198–1206. 1999.
|
|
19
|
Xie W, Yeuh MF, Radominska-Pandya A, et
al: Control of steroid, heme, and carcinogen metabolism by nuclear
pregnane X receptor and constitutive androstane receptor. Proc Natl
Acad Sci USA. 100:4150–4155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen C, Staudinger JL and Klaassen CD:
Nuclear receptor, pregname X receptor, is required for induction of
UDP-glucuronosyltranferases in mouse liver by pregnenolone-16
alpha-carbonitrile. Drug Metab Dispos. 31:908–915. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yueh MF, Huang YH, Hiller A, Chen S,
Nguyen N and Tukey RH: Involvement of the xenobiotic response
element (XRE) in Ah receptor-mediated induction of human
UDP-glucuronosyltransferase 1A1. J Biol Chem. 278:15001–15006.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shelby MK and Klaassen CD: Induction of
rat UDP-glucuronosyltransferases in liver and duodenum by
microsomal enzyme inducers that activate various transcriptional
pathways. Drug Metab Dispos. 34:1772–1778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vyhlidal CA, Rogan PK and Leeder JS:
Development and refinement of pregnane X receptor (PXR) DNA binding
site model using information theory: insights into PXR-mediated
gene regulation. J Biol Chem. 279:46779–46786. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buckley DB and Klaassen CD: Induction of
mouse UDP-glucuronosyltransferase mRNA expression in liver and
intestine by activators of aryl-hydrocarbon receptor, constitutive
androstane receptor, pregnane X receptor, peroxisome
proliferator-activated receptor alpha, and nuclear factor erythroid
2-related factor 2. Drug Metab Dispos. 37:847–856. 2009.
|
|
25
|
Synold TW, Dussault I and Forman BM: The
orphan nuclear receptor SXR coordinately regulates drug metabolism
and efflux. Nat Med. 7:584–590. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kast HR, Goodwin B, Tarr PT, et al:
Regulation of multidrug resistance-associated protein 2 (ABCC2) by
the nuclear receptors pregnane X receptor, farnesoid X-activated
receptor, and constitutive androstane receptor. J Biol Chem.
277:2908–2915. 2002. View Article : Google Scholar
|
|
27
|
Jones SA, Moore LB, Shenk JL, et al: The
pregnane X receptor: a promiscuous xenobiotic receptor that has
diverged during evolution. Mol Endocrinol. 14:27–39. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wentworth JM, Agostini M, Love J, Schwabe
JW and Chatterjee VK: St John’s wort, a herbal antidepressant,
activates the steroid X receptor. J Endocrinol. 166:R11–R16.
2000.
|
|
29
|
Savas U, Wester MR, Griffin KJ and Johnson
EF: Rabbit pregnane X receptor is activated by rifampicin. Drug
Metab Dispos. 28:529–537. 2000.PubMed/NCBI
|
|
30
|
Zhang H, LeCulyse E, Liu L, Hu M, Matoney
L, Zhu W and Yan B: Rat pregnane X receptor: molecular cloning,
tissue distribution, and xenobiotic regulation. Arch Biochem
Biophys. 368:14–22. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng X and Klaassen CD: Regulation of
mRNA expression of xenobiotic transporters by the pregnane X
receptor in mouse liver, kidney, and intestine. Drug Metab Dispos.
34:1863–1867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bauer B, Hartz AM, Fricker G and Miller
DS: Pregnane X receptor up-regulation of P-glycoprotein expression
and transport function at the blood-brain barrier. Mol Pharmacol.
66:413–419. 2004.PubMed/NCBI
|
|
33
|
Chirulli V, Longo V, Marini S, Mazzaccaro
A, Fiorio R and Gervasi PG: CAR and PXR expression and inducibility
of CYP2B and CYP3A activities in rat and rabbit lungs. Life Sci.
76:2535–2546. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Staudinger JL, Goodwin B, Jones SA, et al:
The nuclear receptor PXR is a lithocholic acid sensor that protects
against liver toxicity. Proc Natl Acad Sci USA. 98:3369–3374. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masuyama H, Hiramatsu Y, Mizutani Y,
Inoshita H and Kudo T: The expression of pregnane X receptor and
its target gene, cytochrome P450 3A1, in perinatal mouse. Mol Cell
Endocrinol. 172:47–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dubrac S, Elentner A, Ebner S,
Horejs-Hoeck J and Schmuth M: Modulation of T lymphocyte function
by the pregnane X receptor. J Immunol. 184:2949–2957. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Owen A, Chandler B, Back DJ and Khoo SH:
Expression of pregnane-X-receptor transcript in peripheral blood
mononuclear cells and correlation with MDR1 mRNA. Antivir Ther.
9:819–821. 2004.PubMed/NCBI
|
|
38
|
Albermann N, Schmitz-Winnenthal FH,
Z’graggen K, et al: Expression of the drug transporters MDR1/ABCB1,
MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood
mononuclear cells and their relationship with the expression in
intestine and liver. Biochem Pharmacol. 70:949–958. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lamba V, Yasuda K, Lamba JK, Assem M,
Davila J, Strom S and Schuetz EG: PXR (NR1I2): splice variants in
human tissues, including brain, and identification of neurosteroids
and nicotine as PXR activators. Toxicol Appl Pharmacol.
199:251–265. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dotzlaw H, Leygue E, Watson P and Murphy
LC: The human orphan receptor PXR messenger RNA is expressed in
both normal and neoplastic breast tissue. Clin Cancer Res.
5:2103–2107. 1999.PubMed/NCBI
|
|
41
|
Miki Y, Suzuki T, Kitada K, et al:
Expression of the steroid and xenobiotic receptor and its possible
target gene, organic anion transporting polypeptide-A, in human
breast carcinoma. Cancer Res. 66:535–542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mensah-Osman EJ, Thomas DG, Tabb MM, et
al: Expression levels and activation of a PXR variant are directly
related to drug resistance in osteosarcoma cell lines. Cancer.
109:957–965. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou J, Liu M, Zhai Y and Xie W: The
antiapoptotic role of pregnane X receptor in human colon cancer
cells. Mol Endocrinol. 22:868–880. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Masuyama H, Hiramatsu Y, Kodama J and Kudo
T: Expression and potential roles of pregnane X receptor in
endometrial cancer. J Clin Endocrinol Metab. 88:4446–4454. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Masuyama H, Nakatsukasa H, Takamoto N and
Hiramatsu Y: Down-regulation of pregnane X receptor contributes to
cell growth inhibition and apoptosis by anticancer agents in
endometrial cancer cells. Mol Pharmacol. 72:1045–1053. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gupta D, Venkatesh M, Wang H, et al:
Expanding the roles for pregnane X receptor in cancer:
proliferation and drug resistance in ovarian cancer. Clin Cancer
Res. 14:5332–5340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen Y, Tang Y, Wang MT, Zeng S and Nie D:
Human pregnane X receptor and resistance to chemotherapy in
prostate cancer. Cancer Res. 67:10361–10367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Takeyama D, Miki Y, Fujishima F, Suzuki T,
Akahira J, Hata S, Miyata G, Satomi S and Sasano H: Steroid and
xenobiotic receptor in human esophageal squamous cell carcinoma: a
potent prognostic factor. Cancer Sci. 101:543–549. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pfrunder A, Gutmann H, Beglinger C and
Drewe J: Gene expression of CYP3A4, ABC-transporters (MDR1 and
MRP1-MRP5) and hPXR in three different human colon carcinoma cell
lines. J Pharm Pharmacol. 55:59–66. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiang H, Chen K, He J, Pan F, Li J, Chen
J, Chen W and Liang H: Association of pregnane X receptor with
multidrug resistance-related protein 3 and its role in human colon
cancer chemoresistance. J Gastrointest Surg. 13:1831–1838. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Harmsen S, Meijerman I, Febus CL,
Maas-Bakker RF, Beijnen JH and Schellens JH: PXR-mediated induction
of P-glycoprotein by anticancer drugs in a human colon
adeno-carcinoma-derived cell line. Cancer Chemother Pharmacol.
66:765–771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Habano W, Gamo T, Terashima J, Sugai T,
Otsuka K, Wakabayashi G and Ozawa S: Involvement of promoter
methylation in the regulation of pregnane X receptor in colon
cancer cells. BMC Cancer. 11:812011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Raynal C, Pascussi JM, Leguelinel G, et
al: Pregnane X Receptor (PXR) expression in colorectal cancer cells
restricts irinotecan chemosensitivity through enhanced SN-38
glucuronidation. Mol Cancer. 9:462010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Basseville A, Preisser L, de Carné
Trécesson S, Boisdron-Celle M, Gamelin E, Coqueret O and Morel A:
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling
to detoxification pathway in colon cancer cells. Mol Cancer.
10:802011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zheng XE, Wang Z, Liao MZ, Lin YS, Shuhart
MC, Schuetz EG and Thummel KE: Human PXR-mediated induction of
intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D3
function in human colon adenocarcinoma LS180 cells. Biochem
Pharmacol. 84:391–401. 2012.PubMed/NCBI
|
|
56
|
Wang H, Venkatesh M, Li H, et al: Pregnane
X receptor activation induces FGF19-dependent tumor aggressiveness
in humans and mice. J Clin Invest. 121:3220–3232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Khan F, Amatya B, Ng L, Demetrios M, Zhang
NY and Turner-Stokes L: Multidisciplinary rehabilitation for
follow-up of women treated for breast cancer. Cochrane Database
Syst Rev. 12:CD0095532012.PubMed/NCBI
|
|
58
|
Conde I, Lobo MV, Zamora J, Pérez J,
González FJ, Alba E, Fraile B, Paniagua R and Arenas MI: Human
pregnane X receptor is expressed in breast carcinomas, potential
heterodimers formation between hPXR and RXR-alpha. BMC Cancer.
8:1742008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Meyer zu Schwabedissen HE, Tirona RG, Yip
CS, Ho RH and Kim RB: Interplay between the nuclear receptor
pregnane X receptor and the uptake transporter organic anion
transporter polypeptide 1A2 selectively enhances estrogen effects
in breast cancer. Cancer Res. 68:9338–9347. 2008.
|
|
60
|
Sandanaraj E, Lal S, Selvarajan V, Ooi LL,
Wong ZW, Wong NS, Ang PC, Lee EJ and Chowbay B: PXR
pharmacogenetics: association of haplotypes with hepatic CYP3A4 and
ABCB1 messenger RNA expression and doxorubicin clearance in Asian
breast cancer patients. Clin Cancer Res. 14:7116–7126. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Choi HK, Yang JW, Roh SH, Han CY and Kang
KW: Induction of multidrug resistance associated protein 2 in
tamoxifen-resistant breast cancer cells. Endocr Relat Cancer.
14:293–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chen Y, Tang Y, Chen S and Nie D:
Regulation of drug resistance by human pregnane X receptor in
breast cancer. Cancer Biol Ther. 8:1265–1272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Masuyama H, Suwaki N, Tateishi Y,
Nakatsukasa H, Segawa T and Hiramatsu Y: The pregnane X receptor
regulates gene expression in a ligand-and promoter-selective
fashion. Mol Endocrinol. 19:1170–1180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Takami N, Sakamoto H and Yamamoto T:
Steroid and xenobiotic receptor (SXR) is a key system for the
acquisition of cisplatin resistance in endometrial cancer cells. J
Int Med Res. 31:59–68. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yue X, Akahira J, Utsunomiya H, et al:
Steroid and Xenobiotic Receptor (SXR) as a possible prognostic
marker in epithelial ovarian cancer. Pathol Int. 60:400–406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhang B, Cheng Q, Ou Z, et al: Pregnane X
receptor as a therapeutic target to inhibit androgen activity.
Endocrinology. 151:5721–5729. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Fujimura T, Takahashi S, Urano T, et al:
Clinical significance of steroid and xenobiotic receptor and its
targeted gene CYP3A4 in human prostate cancer. Cancer Sci.
103:176–180. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Maruyama M, Matsunaga T, Harada E and
Ohmori S: Comparison of basal gene expression and induction of
CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull.
30:2091–2097. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Azuma K, Urano T, Ouchi Y and Inoue S:
Vitamin K2 suppresses proliferation and motility of hepatocellular
carcinoma cells by activating steroid and xenobiotic receptor.
Endocr J. 56:843–849. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kodama S and Negishi M: Pregnane X
receptor PXR activates the GADD45beta gene, eliciting the p38 MAPK
signal and cell migration. J Biol Chem. 286:3570–3578. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
van de Winkel A, Menke V, Capello A, et
al: Expression, localization and polymorphisms of the nuclear
receptor PXR in Barrett’s esophagus and esophageal adenocarcinoma.
BMC Gastroenterol. 11:1082011.PubMed/NCBI
|
|
72
|
van de Winkel A, van Zoest KP, van Dekken
H, Moons LM, Kuipers EJ and van der Laan LJ: Differential
expression of the nuclear receptors farnesoid X receptor (FXR) and
pregnane X receptor (PXR) for grading dysplasia in patients with
Barrett’s oesophagus. Histopathology. 58:246–253. 2011.PubMed/NCBI
|
|
73
|
Kawai M, Chen J, Cheung CY and Chang TK:
Transcript profiling of cytochrome P450 genes in HL-60 human
leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid.
Mol Cell Biochem. 248:57–65. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wang T, Ma X, Krausz KW, Idle JR and
Gonzalez FJ: Role of pregnane X receptor in control of all-trans
retinoic acid (ATRA) metabolism and its potential contribution to
ATRA resistance. J Pharmacol Exp Ther. 324:674–684. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zucchini N, de Sousa G, Bailly-Maitre B,
Gugenheim J, Bars R, Lemaire G and Rahmani R: Regulation of Bcl-2
and Bcl-xL anti-apoptotic protein expression by nuclear receptor
PXR in primary cultures of human and rat hepatocytes. Biochim
Biophys Acta. 1745:48–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang K, Damjanov I and Wan YJ: The
protective role of pregnane X receptor in
lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab
Invest. 90:257–265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ouyang N, Ke S, Eagleton N, Xie Y, Chen G,
Laffins B, Yao H, Zhou B and Tian Y: Pregnane X receptor suppresses
proliferation and tumourigenicity of colon cancer cells. Br J
Cancer. 102:1753–1761. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Verma S, Tabb MM and Blumberg B:
Activation of the steroid and xenobiotic receptor, SXR, induces
apoptosis in breast cancer cells. BMC Cancer. 9:32009. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu C, Li J, Wang L, Wu F, Huang L, Xu Y,
Ye J, Xiao B, Meng F, Chen S and Yang M: Analysis of tanshinone IIA
induced cellular apoptosis in leukemia cells by genome-wide
expression profiling. BMC Complement Altern Med. 12:52012.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zimmermann K, Wittman MD, Saulnier MG, et
al: SAR of PXR transactivation in benzimidazole-based IGF-1R kinase
inhibitors. Bioorg Med Chem Lett. 20:1744–1748. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Healan-Greenberg C, Waring JF, Kempf DJ,
Blomme EA, Tirona RG and Kim RB: A human immunodeficiency virus
protease inhibitor is a novel functional inhibitor of human
pregnane X receptor. Drug Metab Dispos. 36:500–507. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Huang H, Wang H, Sinz M, et al: Inhibition
of drug metabolism by blocking the activation of nuclear receptors
by ketoconazole. Oncogene. 26:258–268. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhou C, Poulton EJ, Grün F, Bammler TK,
Blumberg B, Thummel KE and Eaton DL: The dietary isothiocyanate
sulforaphane is an antagonist of the human steroid and xenobiotic
nuclear receptor. Mol Pharmacol. 71:220–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Kliewer SA, Goodwin B and Willson TM: The
nuclear pregnane X receptor: a key regulator of xenobiotic
metabolism. Endocr Rev. 23:687–702. 2002. View Article : Google Scholar : PubMed/NCBI
|
